ES2188656T3 - Composicion antiviral para la cicatrizacion de una herida que contiene un piruvato, un antioxidante, una mezcla de acidos grasos saturados y un compuesto antiviral. - Google Patents
Composicion antiviral para la cicatrizacion de una herida que contiene un piruvato, un antioxidante, una mezcla de acidos grasos saturados y un compuesto antiviral.Info
- Publication number
- ES2188656T3 ES2188656T3 ES95915557T ES95915557T ES2188656T3 ES 2188656 T3 ES2188656 T3 ES 2188656T3 ES 95915557 T ES95915557 T ES 95915557T ES 95915557 T ES95915557 T ES 95915557T ES 2188656 T3 ES2188656 T3 ES 2188656T3
- Authority
- ES
- Spain
- Prior art keywords
- version
- fatty acids
- wound
- compounds
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
INVENCION INCLUIDA DENTRO DE LOS COMPUESTOS PARA LA CURACION DE HERIDAS QUE TIENEN POR FINALIDAD LA PROTECCION Y REANIMACION CELULAR EN MAMIFEROS ( VERSION I (I) ). TAMBIEN SE INCLUYE DENTRO DE LOS COMPUESTOS ANTIVIRALES DESTINADOS AL TRATAMIENTO Y CURACION DE LAS HERIDAS REDUCIENDO LA CONCENTRACION VIRAL C INCREMENTANDO LAS TASAS DE PROLIFERACION Y REANIMACION CELULAR EN MAMIFEROS ( VERSION DOS (II) ). EN UN PRIMER ASPECTO DE LA VERSION UNO (I.A) EL COMPUESTO TERAPEUTICO DE CURACION DE HERIDAS CONTIENE (A) PIRUVATO, (B) UN ANTIOXIDANTE, Y (C) UNA MEZCLA DE ACIDOS GRASOS SATURADOS E INSATURADOS. UN SEGUNDO ASPECTO DE LA VERSION UNO (I.B.) EL COMPUESTO TERAPEUTICO DE CURACION DE HERIADAS CONTIENE (A) PIRUVATO, (B) LACTATO, Y (C) UNA MEZCLA DE ACIDOS GRASOS SATURADOS E INSATURADOS. EN UN TERCER ASPECTO DE LA VERSION UNO (I.C) EL COMPUESTO TERAPEUTICO DE CURACION DE HERIDAS INCLUYE (A) UN ANTIOXIDANTE, Y (B) UNA MEZCLA DE ACIDOS GRASOS SATURADOS E INSATURADOS. UN CUARTO ASPECTO DE LA VERSION UNO (I.D) EL COMPUESTO TERAPEUTICO DE CURACION DE HERIDAS CONTIENE (A) LACTATO, (B) UN ANTIOXIDANTE, Y (C) UNA MEZCLA DE ACIDOS GRASOS SATURADOS E INSATURADOS. EN LA VERSION DOS (II) LOS COMPUESTOS TERAPEUTICOS Y DE CURACION DE HERIDAS DE LA VERSION UNO (I.A-D) SE COMBINAN CON UNA CANTIDAD EFECTIVA DE AGENTE ANTIVIRAL (V) PARA FORMAR COMPUESTOS CURATIVOS ANTIVIRALES (II.AD + V). TAMBIEN SE HACE REFERENCIA A LOS METODOS DE PREPARACION Y USO DE ESTOS COMPUESTOS TERAPEUTICOS Y DE CURACION DE HERIDAS Y A LOS PRODUCTOS FARMACEUTICOS TOPICOS E INGERIBLES CON LOS QUE SE PUEDEN UTILIZAR DICHOS COMPUESTOS TERAPEUTICOS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22493694A | 1994-04-08 | 1994-04-08 | |
US08/410,079 US5856364A (en) | 1991-03-01 | 1995-03-29 | Therapeutic antiviral-wound healing compositions and methods for preparing and using same |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2188656T3 true ES2188656T3 (es) | 2003-07-01 |
Family
ID=26919149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95915557T Expired - Lifetime ES2188656T3 (es) | 1994-04-08 | 1995-04-05 | Composicion antiviral para la cicatrizacion de una herida que contiene un piruvato, un antioxidante, una mezcla de acidos grasos saturados y un compuesto antiviral. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5856364A (es) |
EP (1) | EP0754052B1 (es) |
JP (1) | JPH09511746A (es) |
CA (1) | CA2184617A1 (es) |
DE (1) | DE69529158T2 (es) |
DK (1) | DK0754052T3 (es) |
ES (1) | ES2188656T3 (es) |
MX (1) | MX9604271A (es) |
NZ (1) | NZ283934A (es) |
WO (1) | WO1995027501A1 (es) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5863938A (en) * | 1991-03-01 | 1999-01-26 | Warner Lambert Company | Antibacterial-wound healing compositions and methods for preparing and using same |
US5602183A (en) * | 1991-03-01 | 1997-02-11 | Warner-Lambert Company | Dermatological wound healing compositions and methods for preparing and using same |
US5658957A (en) * | 1991-03-01 | 1997-08-19 | Warner Lambert Company | Immunostimulating wound healing compositions and method for preparing and using same |
TW438585B (en) | 1995-02-06 | 2001-06-07 | Astra Ab | Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections |
US6154445A (en) | 1996-04-18 | 2000-11-28 | Bell Atlantic Network Services, Inc. | Telephony communication via varied redundant networks |
US6069890A (en) | 1996-06-26 | 2000-05-30 | Bell Atlantic Network Services, Inc. | Internet telephone service |
US6078582A (en) | 1996-12-18 | 2000-06-20 | Bell Atlantic Network Services, Inc. | Internet long distance telephone service |
US6137869A (en) | 1997-09-16 | 2000-10-24 | Bell Atlantic Network Services, Inc. | Network session management |
US6574216B1 (en) | 1997-03-11 | 2003-06-03 | Verizon Services Corp. | Packet data network voice call quality monitoring |
US6292479B1 (en) | 1997-03-19 | 2001-09-18 | Bell Atlantic Network Services, Inc. | Transport of caller identification information through diverse communication networks |
US6870827B1 (en) | 1997-03-19 | 2005-03-22 | Verizon Services Corp. | Voice call alternative routing through PSTN and internet networks |
ATE473759T1 (de) | 1998-05-22 | 2010-07-15 | Univ Leland Stanford Junior | Bifunktionelle moleküle sowie darauf basierende therapien. |
AU2763099A (en) | 1998-06-22 | 2000-01-10 | Charles E. Worden | Enriched platelet wound healant |
NZ513711A (en) | 1999-02-26 | 2004-01-30 | Warner Lambert Co | Bioadhesive antibacterial wound healing composition |
ATE396038T1 (de) | 1999-12-28 | 2008-06-15 | Kimberly Clark Co | Antimikrobielles wischtuch mit kontrollierter abgabe für harte oberflächen |
JP5033287B2 (ja) | 1999-12-28 | 2012-09-26 | キンバリー クラーク ワールドワイド インコーポレイテッド | 吸収性物品のための使用依存型指示薬システム |
US6372791B1 (en) | 2000-06-29 | 2002-04-16 | Johnson & Johnson Consumer Companies, Inc. | Method of promoting skin cell metabolism |
US6649176B1 (en) | 2000-06-29 | 2003-11-18 | Johnson & Johnson Consumer Companies, Inc. | Compositions containing mineral water |
US6630175B1 (en) | 2000-06-29 | 2003-10-07 | Johnson & Johnson Consumer Companies, Inc. | Method of reducing eye irritation |
US6432424B1 (en) | 2000-06-29 | 2002-08-13 | Johnson & Johnson Consumer Companies, Inc. | Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid |
US6403652B1 (en) | 2000-06-30 | 2002-06-11 | Colgate-Palmolive Company | Method and composition |
AU2002227052A1 (en) | 2000-11-30 | 2002-06-11 | University Of Florida | Treatments for neurogenetic disorders, impulse control disorders, and wound healing |
US20020169112A1 (en) * | 2001-05-08 | 2002-11-14 | Luc Montagnier | Combined treatments and methods for treatment of mycoplasma and mycoplasma-like organism infections |
US6475526B1 (en) * | 2001-06-05 | 2002-11-05 | Jeffrey B. Smith | Zinc containing compositions for anti-viral use |
DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
US8076373B2 (en) * | 2001-09-11 | 2011-12-13 | North Cell Pharmacetical | Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite |
US20030161851A1 (en) * | 2002-02-14 | 2003-08-28 | Bonne Bell, Inc. | Cosmetic lip product with sour flavor |
US6723307B2 (en) * | 2002-02-14 | 2004-04-20 | Bonne Bell, Inc. | Cosmetic lip product with sour flavor |
US7923023B2 (en) * | 2002-02-25 | 2011-04-12 | Astech International LLC | Method and composition for delivery of medicants to animals |
US7115563B2 (en) | 2002-05-29 | 2006-10-03 | Insignion Holding Limited | Composition and its therapeutic use |
US7258876B2 (en) * | 2003-02-05 | 2007-08-21 | Craig Bozzacco | Topical composition for treating infectious conditions of skin and mucosa |
US20060111442A1 (en) * | 2004-11-20 | 2006-05-25 | Mr. Stanley Antosh | Use of methyl pyruvate to increase cellular energy production downstream of glycolysis for the PARP-1 ablation of HIV without necrotic cell death caused by continuous, chronic PARP-1 activation through the concomitant depletion of ATP and NAD. |
CN103259027A (zh) | 2005-04-28 | 2013-08-21 | 普罗透斯数字保健公司 | 药物信息系统 |
KR20090071598A (ko) | 2006-09-18 | 2009-07-01 | 랩터 파마슈티컬 인코포레이티드 | 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료 |
BRPI0815562A2 (pt) | 2007-07-12 | 2015-02-18 | Novartis Ag | Soluções farmacêuticas orais contendo telbivudina. |
PT2398500T (pt) | 2009-02-20 | 2019-06-14 | 2 Bbb Medicines B V | Sistema de entrega de medicamentos à base de glutationas |
US20120142776A1 (en) * | 2009-04-09 | 2012-06-07 | Leinwand Leslie A | Methods and compositions for inducing physiological hypertrophy |
TWI556839B (zh) | 2009-05-06 | 2016-11-11 | 研究室護膚股份有限公司 | 包含活性劑-磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法 |
EP2368547B1 (en) * | 2010-03-26 | 2012-09-12 | Cesa Alliance S.A. | Antiviral compositions comprising geraniol and carvone |
AR082215A1 (es) * | 2010-07-14 | 2012-11-21 | Vertex Pharma | Composicion farmaceutica agradable al paladar |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
US9671348B2 (en) | 2010-12-13 | 2017-06-06 | Kyowa Medex Co., Ltd. | Method for measuring component by treating aqueous sample with alpha-keto acid and then converting component to hydrogen peroxide |
KR101818286B1 (ko) | 2011-03-28 | 2018-01-12 | 세사 알리안스 에스.에이. | 생체내 치료 용도를 위한 바이러스 억제제 조성물 |
JP2019502776A (ja) | 2015-11-20 | 2019-01-31 | アイエスピー インヴェストメンツ エルエルシー | ラクタム部分を有する増殖性ポリマー |
CN113694198A (zh) * | 2020-05-23 | 2021-11-26 | 陈燕 | 一种从植物及中药材中提取抗病毒成分制造的药剂及方法 |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3887702A (en) * | 1973-08-30 | 1975-06-03 | Mildred Baldwin | Composition and method for treating fingernails and toenails |
US3879537A (en) * | 1973-09-04 | 1975-04-22 | Scott Eugene J Van | Treatment of ichthyosiform dermatoses |
US4294852A (en) * | 1973-11-01 | 1981-10-13 | Johnson & Johnson | Skin treating compositions |
US3984566A (en) * | 1974-02-25 | 1976-10-05 | Scott Eugene J Van | Method of alleviating the symptoms of dandruff |
US3988470A (en) * | 1974-02-25 | 1976-10-26 | Scott Eugene J Van | Treatment of palmar and plant disturbed keratosis |
JPS5132738A (ja) * | 1974-09-13 | 1976-03-19 | Mikio Nakanishi | Kokagakusumotsugunohigaioboshisuru hoho |
US4158057A (en) * | 1975-03-28 | 1979-06-12 | Stanko Ronald T | Prevention of the accumulation of fatty deposits in the liver |
US4197316A (en) * | 1975-07-23 | 1980-04-08 | Scott Eugene J Van | Treatment of dry skin |
US4021572A (en) * | 1975-07-23 | 1977-05-03 | Scott Eugene J Van | Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates |
US4363815A (en) * | 1975-07-23 | 1982-12-14 | Yu Ruey J | Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions |
US4170821A (en) * | 1977-12-02 | 1979-10-16 | Warner-Lambert Company | Razor cartridges |
US4284630A (en) * | 1978-03-22 | 1981-08-18 | Yu Ruey J | Stabilized water-in-oil emulsions |
US4234599A (en) * | 1978-10-04 | 1980-11-18 | Scott Eugene J Van | Treatment of skin keratoses with α-hydroxy acids and related compounds |
US4246261A (en) * | 1979-08-09 | 1981-01-20 | Scott Eugene J Van | Additives enhancing topical corticosteroid action |
JPS5783287A (en) * | 1980-11-14 | 1982-05-25 | Kyowa Hakko Kogyo Co Ltd | Elimination of hydrogen peroxide |
US4548937A (en) * | 1981-04-01 | 1985-10-22 | Montefiore Hospital | Method for preventing body fat deposition in mammals |
US4351835A (en) * | 1981-04-01 | 1982-09-28 | Montefiore Hospital | Method for preventing body fat deposition in mammals |
US4812479A (en) * | 1981-04-01 | 1989-03-14 | The Montefiore Hospital Society Of Western Pennsylvania, Inc. | Method for preventing body fat deposition in mammals |
US4645764A (en) * | 1981-04-01 | 1987-02-24 | Montefiore Hospital | Method for preventing body fat deposition in animals |
US4415576A (en) * | 1981-04-01 | 1983-11-15 | Montefiore Hospital | Method for preventing body fat deposition in mammals |
JPS57194787A (en) * | 1981-05-28 | 1982-11-30 | Ajinomoto Co Inc | Culture medium for animal cell |
US4454159A (en) * | 1981-12-28 | 1984-06-12 | Albert Musher | Dermatological treatment preparations |
DE3201511A1 (de) * | 1982-01-20 | 1983-07-28 | Henkel Kgaa | Sebosuppressive kosmetische mittel, welche laengerkettige alkanole und antioxidantien enthalten |
US4451482A (en) * | 1982-04-22 | 1984-05-29 | Shell Oil Company | Method of preventing or ameliorating pyrethroid skin sensory stimulation |
US4521375A (en) * | 1982-11-23 | 1985-06-04 | Coopervision, Inc. | Sterilizing treatment with hydrogen peroxide and neutralization of residual amounts thereof |
AU565354B2 (en) * | 1983-11-14 | 1987-09-10 | Bio-Mimetics Inc. | Bioadhesive compositions and methods of treatment therewith |
WO1986000227A1 (en) * | 1984-06-22 | 1986-01-16 | Veech Richard L | Electrolyte solutions and in vivo use thereof |
DE3438455A1 (de) * | 1984-10-19 | 1986-06-26 | Institut Dr. Ziegler, Bettingen | L-lysin- und l-histidinpyruvat |
US4696917A (en) * | 1985-08-01 | 1987-09-29 | Lindstrom Richard L | Irrigation solution |
CS262822B1 (en) * | 1986-10-03 | 1989-04-14 | Kovar Jan | Synthetic medium for the cultivation of myelomic cells |
DE3719097C1 (de) * | 1987-06-06 | 1988-06-09 | Fratzer Uwe | Arzneimittel,enthaltend Eicosapentaensaeure und Docosahexaensaeure als ungesaettigte Fettsaeuren sowie Vitamin E |
US4847071A (en) * | 1987-10-22 | 1989-07-11 | The Procter & Gamble Company | Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent |
US4847072A (en) * | 1987-10-22 | 1989-07-11 | The Procter & Gamble Company | Photoprotection compositions comprising tocopherol sorbate |
US4847069A (en) * | 1987-10-22 | 1989-07-11 | The Procter & Gamble Company | Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent |
TR22895A (tr) * | 1988-05-02 | 1988-10-11 | Permatik Celik Ve Plastik San | Platform ve bashk kisimlarinin tamami yardimci tiras malzemesi katkisiyla ueretilen,sulu ortamda kaygan zemin olusturan,bir veya cok bicakh tiras ueniteleri |
EP0345082A3 (en) * | 1988-06-02 | 1990-04-04 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Enzyme formation suppressing agent |
GB8813766D0 (en) * | 1988-06-10 | 1988-07-13 | Efamol Holdings | Essential fatty acid compositions |
CA2018471A1 (en) * | 1989-07-28 | 1991-01-28 | Ian W. Kellaway | Mucoadhesive hydrogels delivery system |
US5084482A (en) * | 1990-04-10 | 1992-01-28 | The Lithox Corporation | Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds |
PH31403A (en) * | 1991-03-01 | 1998-10-29 | Warner Lambert Co | Therapeutic compositions to protect and recuscitate mammalian cells and methods for preparing same. |
WO1993010776A1 (en) * | 1991-11-26 | 1993-06-10 | Warner-Lambert Company | Wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids |
US5296307A (en) * | 1992-05-08 | 1994-03-22 | Electric Power Research Institute, Inc. | Laminated paper polyolefin paper composite |
-
1995
- 1995-03-29 US US08/410,079 patent/US5856364A/en not_active Expired - Lifetime
- 1995-04-05 DE DE69529158T patent/DE69529158T2/de not_active Expired - Lifetime
- 1995-04-05 EP EP95915557A patent/EP0754052B1/en not_active Expired - Lifetime
- 1995-04-05 JP JP7526421A patent/JPH09511746A/ja not_active Ceased
- 1995-04-05 ES ES95915557T patent/ES2188656T3/es not_active Expired - Lifetime
- 1995-04-05 NZ NZ283934A patent/NZ283934A/en not_active IP Right Cessation
- 1995-04-05 CA CA002184617A patent/CA2184617A1/en not_active Abandoned
- 1995-04-05 DK DK95915557T patent/DK0754052T3/da active
- 1995-04-05 WO PCT/US1995/004201 patent/WO1995027501A1/en active IP Right Grant
- 1995-04-05 MX MX9604271A patent/MX9604271A/es unknown
Also Published As
Publication number | Publication date |
---|---|
DK0754052T3 (da) | 2003-03-31 |
US5856364A (en) | 1999-01-05 |
DE69529158T2 (de) | 2003-08-21 |
EP0754052B1 (en) | 2002-12-11 |
DE69529158D1 (de) | 2003-01-23 |
WO1995027501A1 (en) | 1995-10-19 |
CA2184617A1 (en) | 1995-10-19 |
EP0754052A1 (en) | 1997-01-22 |
MX9604271A (es) | 1997-12-31 |
JPH09511746A (ja) | 1997-11-25 |
NZ283934A (en) | 1998-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2188656T3 (es) | Composicion antiviral para la cicatrizacion de una herida que contiene un piruvato, un antioxidante, una mezcla de acidos grasos saturados y un compuesto antiviral. | |
BR9406979A (pt) | Composto,composicão farmaceutica para tratar uma doenca inflamatória suscetivel de tratamento com um agente anti- inflamatório nao esteroidal processos para tratar uma doenca inflamatória e para preparar um composto sal famacéuticamente aceitável uso de um composto composicão farmaceutica anti-inflamatória nao esteroidal | |
ECSP055609A (es) | "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor" | |
AR027533A1 (es) | Derivados de acido malonico, procesos para su preparacion, su uso y composiciones farmaceuticas que los contienen | |
BR9911488A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto | |
MX9200894A (es) | Composiciones terapeuticas para proteger y resucitar las celulas de mamiferos y metodos para preparar y usar las mismas. | |
EA200000920A1 (ru) | Производные бициклических гидроксамовых кислот | |
BR9911482A (pt) | Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto | |
IT1288290B1 (it) | Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie | |
AR007827A1 (es) | 3-ureido-piridofuranos y -piridotiofenos, procedimiento para su preparacion, composicion que los comprende y uso de dichos compuestos para lapreparacion de medicamentos. | |
DE3587434D1 (de) | Antivirale pharmazeutische zusammensetzungen und ihrer verwendung. | |
BRPI0306993B8 (pt) | polímero de polialquilenoglicol ativado; composição; e uso de um composto na produção de um medicamento para o tratamento de esclerose múltipla ou infecção viral suscetível | |
AU7023987A (en) | Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof | |
ES2150496T3 (es) | Cicloalquilimidazopiridinas condensadas. | |
BR9714082A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto. | |
ES2147294T3 (es) | Compuestos terapeuticos. | |
BRPI0113042B8 (pt) | composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato | |
ES2036593T3 (es) | Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas. | |
AR006401A1 (es) | Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos. | |
ES2046176T3 (es) | Composicion farmaceutica que contiene una asociacion de colageno y de un principio activo antiseptico y/o antiinflamatorio y su procedimiento de fabricacion. | |
MX9308013A (es) | 4-fenil-piridonas y 4-fenil-2-fenil-2-alcoxipiridinas sustituidas, procedimiento para su preparacion y medicamentos que los contienen. | |
TR199802769T2 (xx) | Terpenoid bileşikler ile antihistaminik bileşiklerin bir kombinasyonunu ihtiva eden topikal bileşim. | |
AR003176A1 (es) | Una composicion farmaceutica para inhibir el crecimiento de cancer | |
DE69133077D1 (de) | Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung | |
MX9307479A (es) | Uso de ciertos derivados de acido metanobisfosfonico en la curacion de fracturas. |